ENTR'UP Entr'up develops and markets a software tool for managing...
LOUTSA Establishment and development in France and abroad of "coffee factories" (shops) which offer the sale of coffees in bags or bulk, machines and accessories with a tasting...
WATTSENSE Service on-demand for building...
HYSILABS HySiLabs develops an innovative solution to facilitate hydrogen...
PER ANGUSTA Per Angusta develops a SaaS to enhance the performance of procurement...
« Older Entries
The Food and Drug Administration (FDA) issues a favorable opinion on the preclinical development plan submitted by Theranexus and BBDF
Presentation of the results of the phase IB Clinical study of THN201 for Alzheimer’s disease at the clinical trials on Alzheimer’s disease conference (CTAD)
Theranexus et BBDF obtain European “orphan medicinal product” designation for BBDF-101 in Batten disease
Amolyt Pharma Doses First Subject in Phase 1 Clinical Trial of Parathyroid Hormone Analog, AZP-3601, for Hypoparathyroidism
Theranexus presents its latest scientific news